Orlando, FL -- (SBWIRE) -- 10/29/2013 -- Hot Stock Profits provides investors and traders with valuable trading tools and content as well as micro-cap stock alerts via eMail and text messages. To Join Our Text Message Alerts Service Just Text The Word Stocks To 555888 From Your Cell Phone. Our Focus Today Is On Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX), Clovis Oncology Inc (NASDAQ:CLVS).
Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) shares jumped 1.30% to $77.83. The company will report its third quarter 2013 financial results on Tuesday, October 29, 2013 before the financial markets open.
Additionally, the company on Oc.t 17 provided a comprehensive update on recent progress in its research and development activities in cystic fibrosis (CF) aimed at helping more people with CF and enhancing the clinical benefit for these patients with our approved and investigational medicines. Vertex announced that the TRAFFIC and TRANSPORT Phase 3 studies of lumacaftor (VX-809) in combination with ivacaftor in people with two copies of the F508del mutation are fully enrolled.
Are investors worried about the recent updates with VRTX? Find out with a free trend analysis HERE
Clovis Oncology Inc (NASDAQ:CLVS) stock declined 3.64% to $54.86. The company on Oct. 27 announced updated findings from the Phase I portion of its ongoing Phase I/II clinical study of CO-1686, the Company's novel, oral, targeted covalent (irreversible) inhibitor of mutant forms of the epidermal growth factor receptor (EGFR) for the treatment of non-small cell lung cancer (NSCLC) in patients with initial activating EGFR mutations as well as the dominant resistance mutation T790M.
Additionally, the company will announce its third quarter 2013 financial results on Thursday, October 31, 2013, after the market close of the U.S. financial markets.
Is CLVS going to continue its rally or drop like a rock? Find out with a free trend analysis HERE
Join Our Mobile SMS Alerts By Texting Stocks To 555888
HotStockProfits.com continuously monitors and scans the markets for day trading and swing trading signals on NASDAQ, NYSE, AMEX, OTCBB and Pink Sheet companies for its free e-newsletter subscribers.
HotStockProfits.com is not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell securities. Investors should always conduct their own due diligence with any potential investment. Please visit HotStockProfits.com website, for complete risks and disclosures.
Copyright © 2005-2013 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)